Generic Association’s New CEO Signals Focus On Communications
Dan Leonard Replaces Chip Davis At US AAM
Dan Leonard’s communications background, in addition to his policy expertise, may prove useful for the Association for Accessible Medicines as it navigates ongoing market and public policy challenges.
You may also be interested in...
Leonard Resignation Leaves AAM Looking For New Leadership
Dan Leonard has announced his resignation as president and CEO of the US Association for Accessible Medicines. He will be replaced on an interim basis by the group’s vice president for sciences and regulatory affairs, David Gaugh.
US Industry Gears Up For Biden Administration
US off-patent industry association the AAM has welcomed the prospect of working with the incoming Biden-Harris administration, emphasizing that there is “more to be done” to improve generic and biosimilar utilization and uptake.
FDA Talks Tough On Complete Response Extensions
The FDA has published fresh guidance taking a tougher stance on sponsor reasons for needing more time to respond to complete response letters.